Cantor Fitzgerald Maintains Neutral on Gilead Sciences, Lowers Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Olivia Brayer maintains a Neutral rating on Gilead Sciences (GILD) and lowers the price target from $80 to $78.
February 07, 2024 | 6:43 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cantor Fitzgerald analyst Olivia Brayer maintains a Neutral rating on Gilead Sciences and lowers the price target from $80 to $78.
The adjustment in price target by Cantor Fitzgerald reflects a slight negative sentiment towards Gilead Sciences' short-term stock price potential, although the maintenance of a Neutral rating suggests no significant change in the company's overall outlook. This could lead to a neutral short-term impact on GILD's stock price as the market digests this new target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100